एपीए उद्धरण

Moots, R. J., Xavier, R. M., Mok, C. C., Rahman, M. U., Tsai, W., Al-Maini, M. H., . . . Vlahos, B. (2017). The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study. PLoS One.

शिकागो स्टाइल उद्धरण

Moots, Robert J., et al. "The Impact of Anti-drug Antibodies On Drug Concentrations and Clinical Outcomes in Rheumatoid Arthritis Patients Treated With Adalimumab, Etanercept, or Infliximab: Results From a Multinational, Real-world Clinical Practice, Non-interventional Study." PLoS One 2017.

एमएलए उद्धरण

Moots, Robert J., et al. "The Impact of Anti-drug Antibodies On Drug Concentrations and Clinical Outcomes in Rheumatoid Arthritis Patients Treated With Adalimumab, Etanercept, or Infliximab: Results From a Multinational, Real-world Clinical Practice, Non-interventional Study." PLoS One 2017.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.